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ABSTRACT 
Spinal cord injuries are amongst the most serious and debilitating health conditions 
with devastating impact on a patient´s life style, affecting not only its physical but also 
its psychological status and social life. The correct functioning of the nervous system 
depends on the formation of a complex pattern of connections during development. If 
these connections are subsequently lost through injury or degeneration, axons in the 
adult central nervous system fail to regenerate, which is a major clinical challenge. One 
of the main therapeutic strategies for spinal cord injury is to promote axonal 
regeneration. Thus, the use of experimental animal models of spinal cord injury is 
increasing. To allow the identification of molecular mechanisms responsible for axonal 
regeneration, our group has been using the conditioning lesion model, aiming at 
understanding the cellular and molecular mechanisms underlying the improvement of 
the regenerative capacity of central nervous system axons after a primary injury in the 
peripheral nervous system. This model is based on the fact that in dorsal root ganglion 
neurons, when an injury to the peripheral branch occurs before an injury to the central 
branch, the central branch gains regenerative capacity being able to grow through the 
glial scar. In this work we performed the validation of this model in rodents (mice and 
rats) and investigated the role of GSK-3β in promoting axonal regeneration. Our initial 
strategy was to assess the functional recovery of rats after spinal cord injury or 
conditioning lesion and, by retrograde labeling, evaluate, in vivo, the regeneration of 
central branch dorsal root ganglion axons. We established successfully the procedures 
of conditioning lesion and spinal cord injury in our animal facility, and developed a 
detailed post-surgical care of the paraplegic animals. Moreover, we confirmed the 
conditioning lesion effect in the ascending dorsal column tract axons by showing that 
they are capable of regenerating following conditioning lesion. 
Glycogen Synthase Kinase 3β (GSK-3β) has been described as playing a central role in 
regulating axon genesis and elongation. The phosphorylation of GSK-3β Tyr216 results 
in the activation of the kinase, while the phosphorylation of Ser9 leads to its 
inactivation. Given the critical functions that have been attributed to GSK-3β in the 
context of axonal growth, the modulation of its activity may be an important strategy 
for developing successful therapies for central nervous system injuries. To elucidate 
the role that inactivation of GSK-3β might play in the promotion of axonal 
regeneration, we tested several injury models in homozygous GSK-3 Ser21Ala/Ser9Ala 
knockin (GSK-3 KI) mice. In these mice, inactivation of GSK-3 through the 
phosphorylation of these residues is disabled. Through retrograde labeling of 
regenerating axons, we compared axonal regeneration in wild type and GSK-3 KI mice 
after spinal cord injury and conditioning lesion. Qualitative analyses led us to conclude 
that the conditioning lesion effect occurs independently of GSK-3β inactivation 
through Ser9 phosphorylation. However, further studies will be necessary to elucidate 
the role of this kinase in central nervous system regeneration. 
In summary, currently, all the tools are available in our laboratory to evaluate 
functionally and at the molecular level the identity of the molecules involved in axonal 
regeneration and therapeutic approaches for spinal cord injury in mouse and rat 
models. 
 
 
 
  
RESUMO 
As lesões na medula espinal encontram-se entre os mais sérios e debilitantes 
problemas de saúde, com um impacto devastador no estilo de vida de uma pessoa, 
afectando não só o seu estado físico e psicológico, mas também a sua vida social. O 
correcto funcionamento do sistema nervoso depende da formação de complexas 
ligações nervosas durante o desenvolvimento embrionário. Se estas ligações forem 
perdidas após lesão ou degeneração, os axónios do sistema nervoso central adulto não 
conseguem regenerar, o que se tem revelado um grande desafio. Uma das principais 
estratégias em lesões medulares é promover a regeneração axonal. Assim, o uso de 
modelos animais experimentais, de lesões na medula espinal, tem vindo a aumentar. 
Para permitir a identificação de mecanismos moleculares responsáveis pela 
regeneração axonal, e visando comprender os mecanismos celulares e moleculares 
subjacentes ao aumento da capacidade regenerativa em axónios do sistema nervoso 
central, após uma lesão primária no sistema nervoso periférico, o nosso grupo tem 
vindo a utilizar o modelo de lesão condicionante. Este modelo baseia-se no facto de 
que, em neurónios do gânglio da raiz dorsal, quando uma lesão no ramo periférico 
ocorre antes de uma lesão do ramo central, a capacidade regenerativa do ramo central 
aumenta, tornando-se capaz de crescer através da cicatriz glial. Neste trabalho 
efectuámos a validação deste modelo em roedores (ratos e murganhos) e 
investigámos o papel da GSK-3β na promoção da regeneração axonal. A nossa 
estratégia inicial foi avaliar a recuperação funcional de ratos após lesão da medula 
espinal ou lesão condicionante e, através de marcação retrógrada, avaliar, in vivo, a 
regeneração de axónios do ramo central do gânglio da raiz dorsal. Conseguimos 
estabelecer, com sucesso, os procedimentos para a lesão condicionante e para a lesão 
medular no nosso biotério, e desenvolvemos cuidados pós-cirúrgicos detalhados para 
com os animais paraplégicos. Além disso, confirmámos o efeito da lesão condicionante 
no tracto ascendente de axónios dorsais, mostrando que são capazes de regenerar 
após lesão condicionante. 
A Glycogen Synthase Kinase 3β (GSK-3β) tem sido descrita como tendo um papel 
central na regulação da elongação e da genese axonal. A fosforilação da Tyr216 GSK-3β 
resulta na activação da cinase, enquanto a fosforilação da Ser9 leva à sua inactivação. 
Dadas as funções que têm sido atribuídas à GSK-3β, no contexto do crescimento 
axonal, a modulação da sua actividade pode ser uma estratégia importante para o 
desenvolvimento de terapias para lesões do sistema nervoso central. Para elucidar o 
papel que a inactivação de GSK-3β pode desempenhar na promoção da regeneração 
axonal, testámos vários modelos de lesão em murganhos homozigóticos GSK-3 
Ser21Ala/Ser9Ala knockin (GSK-3 KI). Nestes animais, a inactivação da GSK-3 através da 
fosforilação destes resíduos está desactivada. Através da marcação retrógrada de 
axónios em regeneração, comparámos a regeneração axonal em murganhos wild type 
e GSK-3 KI após a lesão medular e lesão condicionante. Análises qualitativas levaram-
nos a concluir que o efeito da lesão condicionante ocorre independentemente da 
inactivação da GSK-3β pela fosforilação da Ser9. No entanto, mais estudos serão 
necessários para elucidar o papel desta cinase na regeneração do sistema nervoso 
central. 
Resumindo, actualmente, o nosso laboratório dispõe de todas as ferramentas 
necessárias, para avaliar funcionalmente e ao nível molecular quais as moléculas 
envolvidas na regeneração axonal, e abordagens terapêuticas para lesões da medula 
espinal em ratos e murganhos. 
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PART 1 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Only the man who is familiar with the art and science of the past 
is competent to aid in its progress in the future”. 
 
(Theodor Billroth) 
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1.1 History  
The first descriptions of spinal cord injuries had origin in the ancient Egypt (3000 - 2500 
years BC). During this era, a great amount of human resources were dedicated to the 
construction of the pyramids which led to a high incidence of trauma, enabling the 
description of a multiplicity of injuries within this population [1]. In 1862, Edwin Smith 
purchased documents (later known as the Edwin Smith Papyrus) from this period 
reporting different traumatic injuries in the human body [1]. Six cases of spine and 
spinal cord injuries were presented with the description of the patient´s history, 
diagnosis and prognosis. One case (“Treatment instructions concerning a crushed 
vertebra of the back of his neck”) reports a complete spinal cord injury, caused by a 
fracture in the cervical region, presenting paralysis of both arms and legs, loss of 
sensation below the level of injury, and loss of urinary bladder control, concluding that 
it was “an ailment not to be treated” [1, 2]. 
Centuries later (460 - 377 BC), Hippocrates analyzed the correlation between vertebral 
and spinal cord injuries. He observed that if the spinal cord injury occurred in one side 
only, a subsequent paralysis would be located on the same side of the damage. He also 
described clinical conditions of chronic paralysis, such as constipation, bladder 
problems, pressure sores, and venous stasis of the lower limbs, as a result of a 
traumatic spinal cord injury. In order to reduce spinal deformities, Hippocrates created 
traction devices (Figure 1), where spinal manipulations were carried out. These 
extension techniques with the application of traction are still widely used today in the 
treatment of spinal disorders [3]. 
During the Greco-Roman era (1st century BC), Aulus Cornelius Celsus documented the 
rapid death as a consequence of cervical spinal cord injury. The Greek Galen (129–199 
AD), described the anatomy of the brain, spinal column and spinal cord, as well as the 
effects of experimental incisions in the spinal cord. He noted that a longitudinal 
incision did not result in any symptoms but a transverse incision at the level of the 
cervical vertebras would result in paralysis and loss of sensory functions below the 
level of injury [1, 3]. He also observed that injuries at the first and second cervical 
vertebrae were fatal, while breathing would stop with injuries at the third or fourth 
vertebrae [4]. 
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After several centuries of stagnation, in 1543, Flemish and Andreas Vesalius published 
the “De Humani Corporis Fabrica”, showing for the first time drawings of the human 
nervous system correctly illustrated [1]. 
 
 
Figure 1 - Hippocratic Ladder (A) and Board (B) devices. To reduce spinal curvatures, the patient was shacked while 
tied on a ladder (A); the weight of the trunk and limbs would act as the pulling force, which would straighten the 
spine. In the Hippocratic Board (B) the patient was placed in a prone position and stretched from the shoulder area 
upward, and from the hips downwards; a wooden board would be placed crosswise over the injured area and its 
compression would lead to deformity reduction. From: [1, 5]. 
 
Charles Bell, in 1824, introduced the concepts of spastic and flaccid paralysis and 
described the concept of spinal shock [1]. Later, in 1858, Charles Edward Brown-
Séquard described spinal cord functions through animal experiments and clinical 
examples and showed that the opening of the spinal canal and the exposure of the 
spinal cord to the air was on itself not dangerous. He also claimed that death following 
spinal fractures was a consequence of spinal cord damage and not due to the primary 
injury; additionally he correlated the urinary infections with spinal cord disorders [6]. 
During the 1st World War, spinal cord injuries associated mortality was as high as 80% 
within the first two weeks after injury. Meanwhile, after perceiving the importance of 
comprehensive care for spinal cord injured victims, the education for the care of spinal 
(A) (B)
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cord injury, little addressed so far, became part of the programs in medical schools 
leading to the creation of rehabilitation programs and to the formation of specialized 
personnel in the care of patients with spinal cord injuries. Thus, from the middle of the 
20th century, an important era of rehabilitation arised with the creation of spinal injury 
associations, which made great contributions to the diagnosis and comprehensive 
management of spinal cord injuries through annual meetings, teaching sessions, 
workshops, and research grants, and with the opening of rehabilitation centres. These 
centres opened the way for better care of spinal cord injured patients, not only 
increasing the patient’s survival but also leading them to readapt to the society. Since 
then the implementation of treatment models and the development of medicine 
prolonged the survival of the patients in about 2000% [1, 3, 4].  
The most recent advances in experimental spinal cord injuries investigation are due to 
the advances of neurobiology [3]. Ramon y Cajal (1900-1920) showed that, in 
mammals, although severed central nerve fibers commenced to regenerate, the 
attempts were abortive and the process was not functionally benefic to the animals. 
During the following decades, experiments on amphibians and reptiles showed that 
regeneration was possible after injury [4]. In the 70´s, Kao transplanted autogenous 
sciatic nerve into the injured spinal cord and succeeded in demonstrating axonal 
growth within the grafted tissue [7]. Research into genetic engineering and stem cell 
studies also began to give its first steps [4]. 
At present, the care of spinal cord injured patients requires knowledge within a variety 
of medical fields and also an interest in development and research. Neuroprotection 
and regeneration are currently the main focus of the latter. Unfortunately, the goal of 
healing the injured spinal cord is still out of reach. However, it is now possible to offer 
several therapeutic measures to improve the health and quality of life of spinal cord 
injured victims, with the aspiration of providing them a long and fulfilling life [1].  
1.2 Spinal Cord Injury Epidemiology 
According with the Council of Europe, in 2001, approximately 90 million people 
worldwide were suffering from some type of spinal cord injury and approximately 
300,000 were paraplegic, only in Europe, as a result of the injury [8]. Unfortunately, 
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insufficient data exist to determine a global prevalence for spinal cord injuries. 
Nevertheless, the range of reported traumatic spinal cord injuries prevalence is 
between 236 and 1009 per million. In Asian countries, the overall prevalence is likely 
underestimated and the only existing data refers to India and Vietnam, with a 
prevalence of traumatic spinal cord injuries of 236 to 464 cases per million. In Western 
Europe, only Finland and Iceland have reported prevalence data, with 280 and 316 per 
million, respectively. In Canada, the prevalence of spinal cord injuries is approximately 
1173 per million whereas in the USA it is estimated at approximately 853 per million 
people [9]. Also in Canada, in 2010, it was estimated that nearly 265,000 people were 
living with spinal cord injuries [10]. The number of injuries occurring around the world 
is alarming. In 2001 the Council of Europe predicted that, each year, 85,000 people 
would survive to a traumatic spinal cord injury, being destined to spend the rest of 
their lives in a wheelchair [8]. Just in the United States, approximately 40 cases per 
million population, not including those who die before reaching the hospital, is the 
estimated annual spinal cord injuries incidence [10], corresponding to 12,000 new 
cases each year [11]. Among the most frequent causes of spinal cord injuries (Figure 
2A) are trauma (mostly related with motor vehicle accidents), falls, construction 
accidents, violence, sports incidents [10], and some illnesses like polio, multiple 
sclerosis, cancer, and arthritis [11]. 
 
 Figure 2 - Major causes (A) and consequences (B) of traumatic spinal cord injuries, in the United States, since 2005 
[10]. 
 
A B 
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0,4% 
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Figure 3 - Global mapping of spinal cord injury from traumatic causes by the World Health Organization regions, 
from 1959 to 2008. Adapted from [9]. 
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Since 2005, the average age at injury is 40.7 years and the majority (80.7%) of spinal 
cord injuries reported in the United States database occurred among males. At hospital 
discharge, incomplete tetraplegia was the most frequent neurologic consequence of 
the injury, followed by complete and incomplete paraplegia and complete tetraplegia. 
Less than 1% of the patients have completely recovered their neurologic functions 
when leaving the hospital [10].  
Although life expectancy for patients with spinal cord injuries remains below the life 
expectancy of those with no injury, it has been significantly improving over the last 40 
years in developed countries when compared with under developed ones [9]. 
Moreover, the mortality rates are significantly higher through the first year after injury 
than in the subsequent years, reflecting the gravity of the injury. Generally, 
tetraplegics have lower survival rates than paraplegics [10]. Developing countries have 
the highest 1-year mortality rates and in some of them the occurrence of a spinal cord 
injury is likely to be fatal in the first year following injury [9]. Until recently, the leading 
cause of death among people with a spinal cord injury was renal failure, meanwhile 
the advances in urologic management have reduced this number of cases. Pneumonia, 
pulmonary embolism and septicemia are currently the main causes of the reduced life 
expectancy for this population [10]. 
 
Table 1 - Economic impact of spinal cord injuries, in the United States, in 2010. 
Severity of injury 
Average Annual Expenses 
Estimated Lifetime Costs by 
Age at Injury 
First Year Each Subsequent Year 25 years old 50 years old 
High Tetraplegia (C1-C4) $985,774 $171,183 $4,373,912 $2,403,828 
Low Tetraplegia (C5-C8) $712,308 $105,013 $3,195,853 $1,965,735 
Paraplegia $480,431 $63,643 $2,138,824 $1,403,646 
Incomplete Motor Functional 
at Any Level 
$321,720 $39,077 $1,461,255 $1,031,394 
Data source: Spinal Cord Injury Facts and Figures at a Glance, National Spinal Cord Injury Statistical 
Center, Birmingham, Alabama, February 2011 [10]. 
 
Due to the nonexistent cure, much has been spent on rehabilitation and comfort of the 
patients. The economic impact on the community with the long term living expenses 
for the care and social welfare support with survivors of a spinal cord injury are directly 
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related and depend from the severity of the injury, reaching however the tens of 
billions of dollars each year (Table 1) [10]. 
1.3 The Spinal Cord 
The nervous system, broadly subdivided into Peripheral Nervous System and Central 
Nervous System, is responsible for controlling all the biological processes in the body. 
The peripheral nervous system is a collection of spinal and cranial nerves whose 
branches spread to all parts of the body transmitting electrical impulses to and from 
the central nervous system composed by the brain and the spinal cord (Figure 5A). 
Regardless of its size and widespread distribution, it contains only two major 
categories of cells (Figure 4):  the neurons, which are the information processors and 
signaling elements, and the glial cells, playing a variety of supporting roles [12]. 
Located within the vertebral canal of the spine, the spinal cord is the part of the 
central nervous system that controls the voluntary muscles of the body, as well as 
most of the viscera and blood vessels of the trunk, and receives their sensory 
information [13].  
 
 
Figure 4 - Cells of the Central Nervous System and their relationships. In contrast to neurons, glial cells do not 
conduct electrical impulses, they surround neurons providing them support. Astrocytes are involved in neuronal 
metabolism, oligodendrocytes are involved in the production of myelin and microglia is part of the immune system. 
The arrow indicates the direction of impulse within the neuron. Adapted from [14]. 
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The human spinal cord can be subdivided into 31 segments (12 thoracic, 5 lumbar, 5 
sacral and 1 coccygeal) [13] (Figure 5B), which give rise to dorsal (posterior) and 
ventral (anterior) rootlets that unite into a pair of dorsal and ventral roots (Figure 6). 
The dorsal roots contain the spinal ganglions, located within the intervertebral 
foramina of the vertebrae and where the dorsal and ventral roots combine into the 
spinal nerves [5]. The spinal nerves are named and numbered according with the 
vertebrae from where they emerge from the vertebral canal. Cervical nerves 1-7 
emerge above their respective vertebrae. Since there are only seven cervical vertebras, 
cervical nerve 8 arises between the 7th cervical (C7) and the 1st thoracic vertebras 
(T1). All the remaining nerves emerge below their respective vertebrae (Figure 5B) 
[13]. 
 
 
Figure 5 - Subdivisions and components of the central nervous system. (A) Division of the nervous system into 
peripheral nervous system and central nervous system. (B) Lateral view representing the major components of the 
central nervous system and indicating the emergence of the segmental nerves (The position of the brackets on the 
left of the image refers to the vertebra). Adapted from [15, 16]. 
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Spinal nerves consist in sensory nerve roots, which enter the spinal cord through the 
dorsal root, and motor roots, which emerge from the cord via ventral roots, at each 
level. Therefore, dorsal roots contain mostly afferent (sensory) fibers whereas ventral 
roots contain efferent (motor) fibers [13]. The cell bodies from the afferent nerve 
fibers, belonging to the peripheral nervous system, are located within the dorsal root 
ganglion [5] where a single axon bifurcates (Figure 6) giving rise to one branch that 
connects with the periphery and another one that connects with the dorsal horn of the 
spinal cord [13]. 
Neuronal cell bodies, dendrites, axons and glial cells originate the grayish color of the 
spinal cord, the gray matter, surrounded by the white matter where the axons of the 
spinal cord are located [12]. 
 
 
 
 
Figure 6 - Diagram of several spinal cord segments with associated nerve fibers. (A) Ventral view. (B) Representation 
of the spinal cord trough a transversal cut. Adapted from [14]. 
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1.4 Spinal Cord Injury: from degeneration to regeneration 
Although the spinal cord is well protected within the vertebral column, spinal cord 
injuries are normally caused by trauma or, but not so often, by health disorders. The 
traumatic event can be either endogenous, as a result for example of an intervertebral 
disc herniation, or exogenous, frequently caused by fractured or dislocated vertebras. 
The initial mechanical trauma to the neural tissue can result from contusion, 
compression, penetration or maceration of the spinal cord [17], and can injure both 
the central nervous system and the peripheral nervous system [18]. Spinal cord injury 
causes the disruption of nerve fibers and local neuronal circuits, interrupting the 
convey of information between the brain and the structures below the injury site [19], 
often resulting in the loss of sensory and motor function [20]. Yet, the consequences of 
injury are not just a break in communication between healthy neurons, but a cascade 
of events that can lead to neuronal degeneration and cell death [21]. Regardless of the 
cause of injury, the resultant pathology arises from primary and secondary injury 
mechanisms. The physical injury to the spinal cord represents the primary injury and 
can lead to severed axons, direct mechanical damage to cells, and ruptured blood 
vessels. Secondary injury is responsible for the expansion of the primary injury and is 
the result of alterations in local ionic concentrations, loss of regulation of local and 
systemic blood pressure, reduced spinal cord blood flow, crash of the blood-brain 
barrier, production of free radicals, imbalance of activated metalloproteinases, and 
release of cytotoxic neurotransmitters [22]. The results of both primary and secondary 
injury mechanisms are the conduction block of neuronal impulses as the result of local 
ionic changes and demyelination, ischemia, necrosis, and apoptosis of spinal cord 
tissue [22]. 
Whereas following peripheral nervous system injury, sensory and motor axons can and 
often do regenerate, the regenerative capacity of the injured adult mammalian central 
nervous system is very limited, usually resulting in permanent neurological deficits 
[23]. While embryonic central nervous system axons can regenerate quite readily, they 
lose this capacity with age [24]. Understanding why injured axons cannot regenerate 
after injury in the adult mammalian central nervous system has been a major challenge 
within the scientific community over the last decades [25]. Upon injury, adult central 
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nervous system axons undergo a spontaneous, but brief and eventually abortive 
attempt on repair reffered to as regenerative sprouting. This indicates that injured 
central nervous system neurons have not necessarily lost their intrinsic property to 
grow, but that they fail to initiate and/or maintain a specific growth programme 
required for axonal elongation [24]. Moreover, previous studies showed that adult 
central nervous system neurons can regrow if they have access to the permissive 
environment of a conditioned sciatic nerve. Further studies have also revealed that the 
failure of central nervous system neurons to regenerate is not an intrinsic deficit of the 
neuron, but rather a characteristic feature of the environment that either does not 
support or prevents regeneration [21]. Important regulators of axonal growth (GAP-43, 
cytoskeletal proteins, transcription factors, neuropeptides, integrins, growth factors 
and neurotrophin receptors) that are expressed during nervous system development 
are re-expressed upon nerve injury. However, in contrast to the peripheral nervous 
system, this event is often merely temporary or completely absent in the central 
nervous system. In addition to a reactivation of growth associated genes expressed 
during development, peripheral axotomy leads to the up-regulation of regeneration-
associated genes (RAGs). These proteins promote axon growth when overexpressed in 
neurons. These observations suggest that expression of growth-associated molecules 
as well as RAGs may be required to trigger successful nerve regeneration [24].  
1.4.1 Wallerian Degeneration 
Following central nervous system lesion, the entire distal segment of the nerve 
degenerates, with desintegration of the distal axonal segment, degradation of myelin 
sheaths and axon cytoskeleton, and the subsequent apoptotic death of 
oligodendrocytes around the lesion site [24]. An additional reason for the different 
regenerative abilities of the peripheral nervous system and central nervous system 
may be the singular sequence of degenerative events after injury, known as Wallerian 
degeneration. Wallerian degeneration begins with axonal degeneration, after which, in 
the peripheral nervous system, the blood-tissue barrier permeability increases, the 
myelin sheath breaks down, and an influx of macrophages occurs to remove the 
cellular and myelin debris distal to the site of axonal injury (Figure 7A). Schwann cells 
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that formerly ensheathed the axons proliferate, align to form longitudinal arrays, and 
increase their production of neurotrophic factors that can promote axon regeneration. 
Proximal to the injury site, neuronal cell bodies react to injury by inducing expression 
of growth-related genes, including those for major components of axonal growth 
cones. The Schwann cell basal lamina and the extracellular matrix also provide a 
favorable substratum for the extension of regenerating axons [16]. In mammals, 
Wallerian degeneration in the peripheral nervous system is fast taking about 7–14 
days. In the mammalian central nervous system, Wallerian degeneration is however 
dramatically slower, taking months to years. These differences are not only due to a 
delay in axonal degeneration in the central nervous system but rather to a failure to 
clear central nervous system myelin debris (Figure7B). The myelin debris have several 
inhibitors of axonal regeneration [26] namely Nogo, myelin-associated glycoprotein 
(MAG), oligodendrocyte-myelin glycoprotein (OMgp), tenascin-R, proteoglycans and 
chondroitin sulfate proteoglycans (CSPGs)  [24]. Astrocytes at the site of injury also 
interfere with regeneration and neurons typically fail to activate the growth-associated 
genes [16]. 
 
 
Figure 7 - Different responses to injury in peripheral (A) and central (B) nervous systems. Adapted from [16]. 
 
Following axonal injury, the primary role of the immune system is to remove toxic 
debris from the injury site. While the magrophages and Schwann cells in the distal 
stumps of the injured peripheral nerves are effective in removing the inhibitory 
proteins associated with myelin, the microglia and oligodendrocytes in the central 
nervous system are not [27]. Therefore, in the peripheral nervous system, rapid 
(B) (A) 
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Wallerian degeneration results in an extracellular environment that promotes axonal 
regeneration, whereas in the mammalian central nervous system, the slow Wallerian 
degeneration results in prolonged presence of myelin-associated inhibitors that likely 
contribute to the failure of central nervous system axons to regenerate [26].  
Moreover, it is important to consider inflammation within the central nervous system 
as a potential source of cytokines and of other signaling molecules that can lead to the 
upregulation of inhibitory pathways after injury. Microglial cells from the central 
nervous system and activated macrophages from the periphery both respond to 
trauma in the brain and spinal cord, and this inflammatory response may contribute to 
secondary tissue damage after the primary insult [28].  
1.4.2 The Glial Scar  
Aside from the inhibitory properties of myelin, microglial cells proliferate along the 
degenerating axons, and hypertrophic astrocytes develop tightly packed filament-rich 
processes underling the formation of a glial scar in the location of the affected nerve 
fibres [29]. Central nervous system injury results in a rapid glial response around the 
injury site. The glial reaction to injury recruits microglia/macrophages, oligodendrocyte 
precursors, meningeal cells, astrocytes, stem cells and fibroblasts [24, 30], leading to 
the formation of a fibrotic glial scar (Figure 8) [24, 31].  
 
 
Figure 8 - Schematic representation of a stereotypical central nervous system lesion. Stab lesion that penetrates the 
meninges and allows fibroblast invasion in addition to macrophages. Axons are highly repulsed by the increasing 
gradient of chondroitin sulfate proteoglycans (CSPGs) and keratan sulfate proteoglycans (KSPGs). Several other 
inhibitory molecules are also made in this type of injury and are especially prevalent in the core of the lesion. ECM, 
extracellular matrix; TGF, transforming growth factor. Adapted from [32]. 
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Although it contributes to seal the injury site from the spared tissue, possibly 
preventing the spread of the secondary injury, the glial scar is far more than just a 
physical barrier [28]. It is the source of factors such as tenascic acid, semaphorins, 
ephrins, and various proteoglycans, that make the biochemical milieu surrounding the 
injury site inhospitable for regenerating axons [22]. The glial scar thus forms both a 
mechanical and a molecular barrier to axonal growth [24]. Therefore axons cannot 
regenerate beyond it, and take on a dystrophic appearance of stalled growth. Recent 
studies have indicated that axons with dystrophic endings do not lose their ability to 
regenerate, and that they can in fact return to active growth states [32]. The 
significance of the persistence of such unusual “growth cones” within the lesion 
implies that some type of cytoskeletal and/or membrane plasticity must be occurring 
to maintain axonal viability and stability, even though the axons remain without 
forming synapses [32]. 
1.4.3 Axonal Regeneration 
After injury to the adult mammalian central nervous system, the resulting failure of 
axonal regeneration can be attributed to myelin-associated inhibitors, the glial scar, 
and the neuronal intrinsic growth status [33]. Physical injury to the spinal cord results 
in the mechanical disruption and degeneration of ascending and descending axons. 
One of the main therapeutic strategies for spinal cord injuries is to promote axonal 
regeneration [22]. Although axonal regeneration is extremely limited in the adult 
mammalian central nervous system, partial lesions of the spinal cord can be followed 
by spontaneous, and often substantial, functional improvements [34]. Research on 
nerve regeneration has been focused on identifying the inhibitory factors present in 
the environment. However much less is known about the mechanisms that activate 
the intrinsic growth capacity of neurons following injury [35]. A substantial amount of 
research suggests that increasing the growth potential of damaged sensory neurons 
enables them to overcome inhibition in the injured peripheral nervous system and 
central nervous system [36].  
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1.5 The Consequences of Spinal Cord Injury  
Acute traumatic spinal cord injury is an unexpected, catastrophic event. Its 
consequences often persist for the life of the patient and influence in several ways not 
only the patient, but also its family members and society at large [37]. 
Human spinal cord injury often results from an insult to the spinal column and by 
contusion injury. There is the subsequent displacement of the spinal cord due to the 
pressure from the broken bone, disk fragments and hematoma and swelling inside the 
closed vertebral canal [13]. This injury has a serious effect on the spinal cord segment 
with the breakdown of connections and networks and the development of a spinal 
cord scar. The functional consequences of such an injury are associated with 
autonomic paralysis including dysfunctional internal organs, limb muscle atrophy, 
sensory impairment, and chronic pain [38]. Phantom sensations are also frequent [39]. 
These symptoms are often lifelong persistent because of the inability of the lesioned 
fibres to regenerate [40]. The consequences of a spinal cord injury may vary depending 
on the type, level, and severity of injury. Complete injuries lead to the loss of function 
below the level of injury, resulting in the absence of motor and sensory function. In 
incomplete injuries, some sensation and/or movement below the level of injury is 
retained.  
 
 
 
 
Figure 9 - Levels of injury and extent of paralysis. Injury to specific levels of the spine can cause spinal cord injuries. 
Varying degrees of nerve damage often result in paralysis bellow the lesion site. From: [44]. 
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A spinal cord injury at the neck level may result in tetraplegia and impair the ability to 
breathe. Injuries to the lower spine may cause weakness and loss of sensation in the 
legs and lower parts of the body, and paraplegia (Figure 9). Complications such as loss 
of bladder and bowel control, increased risk for urinary tract infections, sexual 
dysfunction, skin breakdown and pressure sores, spasticity, inability or reduced ability 
to regulate heart rate, blood pressure and body temperature, autonomic dysreflexia, 
muscle atrophy, blood clots, osteoporosis and cardiovascular disease can result from 
injury and from the consequent reduced physical activity [41]. Also, the inability to 
maintain body weight within prescribed ranges occurs in a significant proportion of the 
human spinal cord injured population. In general, clinical reports indicate that spinal 
cord injured patients are at risk for a lifelong inability to maintain a neutral energy 
balance. Nutritional deficits leading to an underweight body mass in spinal cord injury 
present a number of risk factors to the individual in both the acute and chronic phases 
of injury. Low body weight increases the risk of developing infection and prolongs the 
recovery process from major traumatic injury. Furthermore, insufficient subcutaneous 
fat mass increases the risk of developing pressure ulcers. The presentation of recurrent 
pressure ulcers, in turn, is a comorbidity that triggers proinflammatory cytokine 
release, which can exacerbate the cachexic state of the patient [42]. 
The symptoms of spinal cord damage usually appear immediately after injury. 
However, if an infection or tumor is gradually increasing pressure on the spinal cord, 
they can develop slowly [41].   
1.5.1 Bladder Dysfunctions 
Bladder dysfunction is considered one of the top concerns among paraplegics and 
tetraplegics, usually of higher importance than the loss of locomotion [43]. The 
functions of the lower urinary tract to store and periodically release urine are 
regulated by a complex neural control system located in the brain and spinal cord, 
which functions like a switching circuit to maintain a reciprocal relation between the 
bladder, urethra and urethral sphincter [44]. This dependence on central nervous 
system control distinguishes the lower urinary tract from many other visceral 
structures that maintain a certain level of function even after elimination of extrinsic 
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neural input [45].  
Voluntary micturition is regulated by a mechanism in the spinal and supraspinal neural 
pathways [44]. The central nervous system communicates with the lower urinary tract 
via three sets of peripheral nerves: sacral parasympathetic nerves that provide an 
excitatory input to the bladder and an inhibitory input to the urethra; lumbar 
sympathetic nerves that excite the urethra; and sacral somatic nerves that excite the 
urethral sphincter. Sympathetic and somatic pathways to the urethra and the 
sphincter are activated by spinal reflex mechanisms during urine storage. However, 
during voiding, parasympathetic excitatory input to the bladder, as well as inhibition of 
sympathetic and somatic control of the urethral outlet, are mediated by supraspinal 
mechanisms [46]. Spinal cord injury rostral to the lumbosacral level disrupts this 
voluntary and supraspinal control of voiding, leading to a marked reorganization of the 
micturition reflex pathways that coordinate bladder and sphincter function [44]. 
Previous studies have shown that chronic spinal cord injured rats exhibited impaired 
voiding, distended, hypertrophied bladders, and hypertrophied afferent neurons [47].   
Spinal cord injury initially induces an areflexic bladder and urinary retention followed 
by the emergence of automatic micturition mediated by spinal reflex pathways. The 
urinary bladder becomes hypereflexic along with tonic activity of urethral sphincter. 
These lower urinary tract dysfunctions then produce various urological problems such 
as urinary incontinence, recurrent urinary tract infections, that can result in sepsis, and 
vesicoureteral reflux with or without upper urinary tract deterioration [44]. An 
additional consequence of spinal cord injury is a high intravesical bladder pressure, 
which can lead to damage and hypertrophy of the smooth muscle mass, accompanied 
by an enormous enlargement of the urinary bladder [48]. 
1.6 Animal Models of Spinal Cord Injury 
There is an increased usage of experimental animal models of spinal cord injury. The 
aims of these models are to better understand the acute and chronic morphological, 
cellular and molecular consequences of spinal cord injuries and, with this information, 
develop and test new therapies to enhance anatomical repair and functional recovery. 
From a therapeutic point of view, even partial restoration of damaged spinal tracts 
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following spinal cord injury could result in improvements in respiratory function, 
upper/lower limb function, and bowel/bladder/sexual function [13]. The development 
of a rational approach for the treatment of traumatic spinal cord injury requires a 
standardized and reproducible animal model in which a quantifiable trauma can be 
correlated with functional recovery and morphology of the lesion [49]. Of the many 
traumatic spinal cord injury models, the most frequently used methods of injury 
include complete transection or hemissection (dorsal transection). Although these 
types of laceration injuries are not typically seen clinically, they can effectively 
disconnect both ascending and descending axonal pathways at designated levels of the 
spinal cord. This approach allows the study of mechanisms that govern the inhibition 
or successful regeneration of axons across or around injury as well as of the resulting 
functional deficits and potential recovery. Importantly, the severity and level of the 
spinal cord injury entirely dictate the applicability of quantitative assessments for 
impaired motor, sensory, and/or autonomic functions [50].  
Mice and rats have been the models of choice for evaluating the effects of various 
procedures aimed at reducing damage to the spinal cord or at promoting axonal 
regeneration [49]. As experimental models they appear to be a satisfactory species for 
spinal cord studies, since they are able to tolerate the rigors of experimentation and 
have the further advantage of economy and availability [37]. 
Mice and rats are in many ways well suited to the assessment of nerve regeneration. 
However, they present special challenges because of their small size, their inherent 
capacity for regeneration, and the potential strain effects. For regeneration of 
interrupted fibers, histological and physiological measures have the advantages of 
allowing the direct correlation with restoration of function [51]. 
1.6.1 Mouse / Rat Spinal Cord 
There are many differences between the nervous system of humans and that of the 
animals commonly used in spinal cord injury studies. Issues such as size, gait, 
neuroanatomical, neurophysiological and behavioral differences, as well as disparities 
in immunological and inflammatory responses following spinal cord injury, point to 
potential limitations of animal models when assessing the efficacy and safety of 
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possible spinal cord injury treatments in humans. The importance of size differences 
between animal spinal cord injury models and humans is reflected in the distances 
over which axons are required to regenerate after injury.  This may affect comparisons 
between regeneration studies in rodents versus primates, especially with injuries to 
the cervical and thoracic spinal cord  [13].  
In contrast to humans, where the spinal cord has 31 segments, the rat spinal cord is 
made up of 34 segments: 8 cervical (C1 to C8), 13 thoracic (T1 to T13), 6 lumbar (L1 to 
L6), 4 sacral (S1 to S4), and 3 coccygeal (Co1 to Co3) [13]. 
1.7 The Conditioning Lesion Model  
Primary sensory neurons with cell bodies in the dorsal root ganglion, that have a 
central axon that ascends in the dorsal column, provide an useful model system to 
study the mechanisms that regulate regeneration [35]. Dorsal root ganglion neurons 
have two axonal branches stemming from an unipolar axon, a peripheral branch that 
regenerates when injured and a central one that enters the central nervous system 
and does not regenerate [52]. Remarkably, injury to the peripheral branch before 
injury to the central branch promotes regeneration of central axons (Figure 10).  
 
 
 
Figure 10 - Conditioning injury paradigm. Dorsal root ganglion neurons have two axonal branches; a long sensory 
central nervous system branch that ascends the dorsal column in the spinal cord and a second branch that projects 
trough a peripheral nerve. In the conditioning lesion, a peripheral nerve lesion (PNL) prior to the dorsal column 
lesion (DCL) leads to regeneration in the central nervous system branch. Adapted from [53]. 
 
This phenomenon known as Conditioning Lesion paradigm suggests that retrograde 
injury signals travel from the peripheral injury site back to the cell body to increase the 
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intrinsic growth capacity of the neuron [35]. Under these circumstances, not only does 
the peripheral axon regrow in the peripheral nervous system, but their central axon in 
the dorsal column of the central nervous system is also capable of regenerating (Figure 
11) [53]. This conditioning effect has been documented in both sensory and motor 
neurons in the mammalian peripheral nervous system [35]. Although central 
regeneration is relatively meager (on the order, at top, of a few millimeters) this result 
has stimulated a renewed excitement on understanding the conditioning effect [36].  
 
 
Figure 11 - Conditioning lesion effect. Sensory axons in the adult spinal cord do not regenerate after injury (A-C), 
while prior peripheral injury results in a robust regenerative response (D-E). Pre-conditioned neurons express RAGs 
and are growth competent prior to central injury (D). They start to regenerate immediately upon a central lesioning 
(E) and cross the injury site (F). Several experimental manipulations result in axonal regeneration in the central 
nervous system when applied before or at the time of injury, but not when initiated after a delay, which would be 
clinically more relevant. Adapted from [54]. 
 
Furthermore, other studies showed that dorsal root ganglion neurons could 
regenerate their central axons into peripheral nerve explants (inserted into the dorsal 
column of the spinal cord) only if the peripheral axon of the dorsal root ganglion had 
been previously cut. These observations suggested that the acquired regenerative 
competence of dorsal root ganglion neurons depended on some form of cell body 
activation in response to the peripheral injury. It is now known that axotomy of the 
peripheral axon, in contrast to axotomy of the central one, triggers altered expression 
of several RAGs in the dorsal root ganglion cell bodies [55]. 
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Axonal regeneration is enhanced if second injury occurs 1-2 weeks after the intrinsic 
growth state has been increased by the prior conditioning lesion. Improved 
regeneration is characterized by accelerated outgrowth, a reduction in the lag time 
between the time of injury and the onset of elongation, and an increase in the number 
of regenerating sprouts. The intrinsic growth state increases substantially after the 
injury of peripheral branches, increases less effectively  after dorsal root lesion, and 
does not increase at all after spinal cord injury [56]. 
Nevertheless, the cell body of injured neurons must receive accurate and timely 
information on the site and extent of axonal damage in order to orchestrate an 
appropriate response leading to successful regeneration. The conditioning lesion 
suggests that distinct signaling mechanisms regulate the responses to a central versus 
a peripheral injury that may contribute to the different abilities of axonal regrowth 
[35]. Several studies provided evidence for the existence of multiple injury signals 
functioning in a temporal sequence: injury-induced discharge of axonal potentials, 
interruption of the normal supply of retrogradely transported target-derived factors 
(also called negative injury signals) and retrograde injury signals traveling from the 
injury site back to the cell body (also called positive injury signals) (Figure 12)[35].  
 
 
 
Figure 12 - Signaling mechanisms. Distinct signaling mechanisms may act in complementary and synergistic 
manners: (1) injury-induced discharge of axonal potentials, (2) interruption of the normal supply of retrogradely 
transported trophic factors or negative regulators of neuronal growth derived from the target, and (3) retrograde 
transport of activated proteins emanating at the injury site, termed positive injury signals. From: [35]. 
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The retrograde transport of injury signals is one of the essential cellular mechanisms 
leading to regeneration. Coordination between several injury-signaling pathways is 
necessary to regulate the appropriate genes to promote neuronal survival and increase 
the intrinsic growth state of injured neurons [35]. Furthermore, neurons projecting 
into the peripheral nervous system respond to injury of their peripheral axon with 
characteristic changes in gene expression of transcription factors, cytoskeletal and 
cytoskeletal regulatory proteins, cell adhesion and axonal guidance molecules, trophic 
factors and cytokines (including their receptors), neuropeptides and neurotransmitter-
synthesizing enzymes, ion channels, and membrane transporters [55].  
1.8 The Glycogen Synthase Kinase - 3β Pathway in Axonal 
Regeneration 
Development and regeneration of the nervous system requires the precise formation 
of axons and dendrites [57], in which biochemical signaling pathways are known to 
have a critical role [58]. A growing body of evidence is accumulating to suggest that 
signaling pathways also underlie neurodegeneration and neurodegenerative diseases 
[58]. Kinases and phosphatases are pervasive regulators of cellular function and have 
been implicated in controlling axodendritic development and regeneration. Aside from  
regulating neuronal differentiation, including axon formation and elongation, 
phosphorylation controls most cellular processes, including the cell cycle, proliferation, 
metabolism and apoptosis [57]. In addition, signaling pathways like MAPK, growth 
factor signaling, PIP3, cytoskeletal, and calcium-dependent pathways have been shown 
to impinge on or control neuronal process development [57]. 
Glycogen Synthase Kinase 3 (GSK-3) is a serine/threonine kinase that was first isolated 
and purified as a key enzyme involved in the glycogen synthesis. Beyond its role in 
glycogen metabolism and insulin signaling [59], GSK-3 plays a role in the transduction 
of regulatory and proliferative signals arising from out of the cells [60], and is thought 
to play an important role in critical physiological processes, such as the cell cycle, 
neuronal function, oncogenesis, apoptosis, and embryonic development [61]. The 
pathways in which GSK-3 acts as a key regulator have been implicated in the 
development of a wide variety of human diseases, such as diabetes, cancer, 
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inflammation, Alzheimer´s disease, schizophrenia, attention deficit hyperactivity 
disorder, and bipolar disorder [60]. Thus, it is not surprising that GSK-3 inhibitors are 
being actively developed as drugs for the treatment of various disorders [59]. 
In vertebrates, GSK-3 is found as two isoforms: GSK-3α and GSK-3β [59]. They both 
have similar functions; however they are not functionally redundant since deletion of 
GSK-3β leads to embryonic lethality due to hepatocyte apoptosis. Nonetheless, in 
certain pathways both of the isoforms are implicated, as is the case, in axon formation 
in hippocampal neurons [59]. Unlike other kinases, GSK-3 is constitutively active in 
cells and its activity, controlled by phosphorylation, is responsible for cell signaling 
[62].  
Upstream signals downregulate its activity by phosphorylation at specific residues. The 
most important phospho-residues are Ser21 for GSK-3α and Ser9 for GSK-3β, which 
inhibit its kinase activity, while phosphorylation on Tyr residues (Tyr216 for GSK-3β and 
Tyr279 for GSK-3α), is required for its activation [63]. Structural and biochemical 
studies indicate that phosphorylated Ser9 acts as a pseudosubstrate for GSK-3β, by 
binding to Arg96, a residue that normally interacts with the phosphorylated site of 
primed substrates [58]. Numerous kinases, including the Ser/Thr protein kinase C (PKC) 
and Akt-1 [60] can phosphorylate GSK-3β at Ser9 . The ability of Akt to phosphorylate 
GSK-3β at its inhibitory site is intriguing, given the prominent role of the Akt signaling 
pathway in neuroprotection [58]. GSK-3 is also inhibited in response to secreted 
glycoproteins, termed Wnts, that function in a pathway that is crucial for the 
specification of cell fates during embryonic development [64]. Phosphorylation of the 
residue Tyr216 results in the constitutive activity of GSK-3β [62]. Physiological levels of 
calcium have been shown to increase Tyr216 phosphorylation of GSK-3β. In addition, 
proapoptotic stimuli increase GSK-3β activity through increased Tyr216 
phosphorylation [58]. In mammalian cells, this seems to be an intramolecular 
autophosphorylation event that plays an important role in stabilizing the enzyme [64], 
and it is believed to be an important target for signal transduction [62]. Several studies 
provide evidence that activation of GSK-3β contributes to neuronal apoptosis and that 
the phosphatidylinositol 3-kinase (PI3K)/Akt pathway may protect neurons by 
inhibiting GSK-3β [58]. GSK-3β sits at the convergence of several signaling pathways 
that are critical for neuronal viability and proper function. Several apoptotic stimuli 
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appear to be involved in pathways that activate GSK-3β. Conversely, neuroprotective 
stimuli lead to an inactivation of GSK-3β. Prominent in this latter category is the 
PIK3/Akt pathway. Thus, GSK-3β activity appears to be correlated inversely with 
neuronal viability [58].  
Its role in phosphorylation of cytoskeletal proteins impacts on neuronal plasticity, as 
cytoskeletal constituents are involved in the development and maintenance of 
neurites, and changes in the rate of stabilization/destabilization of microtubules could 
influence major cellular compartments of neurons, such as dendrites, spines, axons, 
and synapses [63]. It has been shown that Akt-1 and GSK-3β have multiple roles in 
axonal and dendritic development and establishment and maintenance of neuronal 
polarity [60].  
 
 
 
 
Figure 13 - Schematic representation of the essential aspects for axonal microtubule assembly in axons, regulated 
by GSK-3β: microtubule polymerization, stabilization and dynamics. To promote axonal assembly, neurotrophins 
inactivate GSK-3β by phosphorylation of Ser9 via the PI3K/Akt signaling pathway. Phosphorylation of GSK-3β allows 
dephosphorylation of CRMP-2 and APC, promoting microtubule polymerization and stabilization. Neurotrophins 
enhance the activity of GSK-3β toward MAP1b (independent of Ser9 phosphorylation) via the ERK pathway. 
Phosphorylation of MAP1b ensures maintenance of microtubule dynamics. Coordinated regulation of these 
pathways ensures optimal axonal microtubule assembly. Adapted from: [65] 
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GSK3 activity also depends on its cellular localization. Althoug GSK-3 is predominantly 
located in the cytosol, it is also present in nuclei and mitochondria, where it is highly 
activated when compared to the cytosolic pool. Nuclear GSK-3 regulates the 
expression of diverse genes via various transcription factors, such as Ap-1, β-catenin, c-
myc, and p53. Subtle control of GSK3-mediated activation and inhibition is required to 
ensure proper balance among cell morphoregulation, proliferation, and growth. 
Prolonged inhibition of GSK-3 is associated with hypertrophic cell growth, while 
sustained activation is associated with neurodegeneration [63]. 
Microtubules are the principal cytoskeletal components of axons. Thus, control of 
microtubule polymerization and stability is a key regulatory step in axon growth during 
development and regeneration after nerve injury [65]. Given the critical function of 
GSK-3 in regulating axon genesis and elongation, modulation of GSK-3β activity may be 
an important strategy for developing successful therapies for central nervous system 
axonal injuries [66].  
 
PART 2 
INDUCTION OF THE INTRINSIC CAPACITY OF AXONAL 
REGENERATION THROUGH A CONDITIONING LESION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The frog instantly dies when the spinal cord is pierced;  
And previous to this it lived without head, without heart 
or any bowels or intestines or skin; and here therefore  
it would seem lies the foundation of movement and life”.  
 
(Leonardo da Vinci) 
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2.1 INTRODUCTION  
Upon injury, regeneration of adult central nervous system axons is abortive. This lack 
of regeneration appears to be due to both a decreased intrinsic ability of central fibers 
to grow, and to the inhospitable environment [24]. In contrast to the central nervous 
system, after axonal injury, peripheral nerve fibres are able to regenerate [67]. A 
frequent injury occurring in the central nervous system is the spinal cord injury. This is 
a global concern affecting millions of people worldwide. Every year the number of 
patients who survive spinal cord injuries increase, leading thousands of people to 
initiate a daily routine of medical care.  
Due to the inexistence of a cure, the identification of mechanisms that allow central 
nervous system regeneration is a major challenge in the neuroscience field. 
To increase the knowledge in this area, the use of animal models of central nervous 
system injury is of major importance, allowing to test and identify mechanisms 
promoting axonal regeneration. 
The conditioning lesion model has been widely used in our group. This model is 
described as being able to promote de intrinsic capacity of central nervous system 
axons to regrow upon injury. This model is based on the manipulation of sensory 
neurons in the dorsal root ganglion. These neurons possess two axonal branches: a 
peripheral axon that regenerates when injured and a centrally projecting axon that 
does not regenerate following injury. However, in this model, an injury to the 
peripheral branch promotes regeneration of the central axons [35]. 
In order to validate the conditioning lesion model in our laboratory and identify 
additional molecules capable of inducing regeneration, this model was evaluated and 
characterized.   
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2.2 OBJECTIVES  
 
The main objective of this work was to evaluate and characterize the conditioning 
lesion model, in rats. This will allow the validation of this model in our laboratory and 
the future identification of new molecules/therapeutic strategies with the ability of 
increasing axonal regeneration. In order to achieve these goals we evaluated: 
1. The functional recovery of rats post-surgery (either spinal cord injury or 
conditioning lesion), particularly the ability of the different groups to regain 
bladder control; 
2. Axonal regeneration by retrograde labeling of ascending dorsal column tract 
axons through cholera toxin injection in the sciatic nerve. 
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2.3 MATERIAL AND METHODS 
2.3.1 Animals and Animal Care 
As animal models of injury, 8-10 weeks old Wistar rats were used. All animals were 
handled according to the European Communities Council Directive (86/609/EEC) and 
National rules and all procedures were approved by the Portuguese General 
Veterinarian Board. Animals were maintained at 22 ± 1ᵒC under a 12 hr light/dark cycle 
and fed with regular rodent chow and tap water ad libitum. All surgical procedures 
were preceded by anesthesia with a Medetomidine and Ketamine mixture (0.5 mg/kg 
and 75 mg/kg body weight, respectively) via intra peritoneal injection. At the end of 
the study, or at humane endpoints, all animals were euthanized with a 20% 
Pentobarbital overdose. Humane endpoints were determined trough the visualization 
of persistent pain or distress. Prolonged abnormal posture, dyspnea, chronic weight 
loss (more than 20% after sciatic nerve injury or more than 25% after spinal cord 
injury), prolonged porphyrin staining, self-induced trauma, rupture of the urinary 
bladder and extended dehydration were also signs for humane endpoint. After death 
confirmation, skeletal remains were frozen and sent for incineration according to the 
dispatch 242/96 August 13.  
2.3.2 Surgical Procedures and Post-Surgical Care 
2.3.2.1 Sciatic Nerve Injury 
Animals were anesthetized with a Medetomidine and Ketamine mixture (0.5 mg/kg 
and 75 mg/kg body weight, respectively) via intra peritoneal injection, and 3.0 mL of a 
5% glucose saline solution was injected subcutaneously. In order to expose the sciatic 
nerve, the mid thigh was shaved and a 2.0 cm long incision was made. Local anesthesia 
(Articaine Hydrochloride / Epinephrine, 72 mg and 0.018 mg / 1.8 mL) was injected on 
the thigh (0.3 mL in case of unilateral lesion and 0.2 mL in each thigh in case of 
bilateral lesion). Transection with a microscissor or crush using Pean forceps, was 
performed in the sciatic nerve immediately distal from the sciatic notch. The animals 
were awaked with Atipamesol (5 mg/kg) and analgesia was performed through 
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subcutaneous injection of Butorphanol (1.0 mg/kg) twice a day for 48 hr following 
injury. 
2.3.2.2 Spinal Cord Injury  
Animals were anesthetized as previously described and kept warm with heating pads. 
In order to compensate for the diuresis caused by anesthesia, and for the blood loss, a 
fluid supplement of 3.0 mL of 5% glucose saline solution was subcutaneously injected. 
The skin was then shaved along the vertebral column and one incision was performed 
through the thoracic vertebras 6 to 11 (T6-11). Under a microscope, the vertebral 
column was exposed and with a bone rongeur, the thoracic vertebra 7 (T7) was 
removed followed by spinal cord hemisection with a microscissor. Post surgical 
treatment consisted in fluid therapy with daily subcutaneous injection of 5.0 mL of 
Duphalyte® and analgesia, every 12 hr, through subcutaneous injection of Butorphanol 
(1.0 mg/kg) for the next 72 hr after injury. Crede's manoeuvre (manual bladder 
voiding) was performed twice a day until the end of the experiment or until the 
animals recovered their bladder control. Wet food was placed in the cage floor and the 
drinking water, supplemented with 0.016% Enrofloxacin to prevent infections, was 
supplied in long nipple bottles.  
2.3.2.3 Conditioning Lesion 
Animals were subjected to sciatic nerve injury and one week later spinal cord injury 
was performed. 
2.3.3 Assessment of Recovery After Surgery 
The observation and evaluation of the animals was carried out by recording daily the 
body weight, by analyzing the presence of blood in the urine, and by assessment of 
recovery of bladder control and mobility. Score sheets were kept for all animals. 
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2.3.4 Assessment of Axonal Regeneration in vivo  
Six weeks after spinal cord injury or conditioning lesion, animals were anesthetized 
and the left sciatic nerve was exposed as previously described. To label ascending 
regenerating axons, 2.0 μL of 1% Cholera Toxin β (CTβ, List Biologicals) was injected in 
the sciatic nerve distally of the sciatic notch. The skin was then sutured and analgesia 
was carried out as described for sciatic nerve injury procedures. Four days later, 
animals were anesthetized and transcardially perfused with 40.0 mL Phosphate 
Buffered Saline (PBS), followed by 80.0 mL of 4% Paraformaldehyde (PFA). The spinal 
cords were then collected, postfixed overnight at 4ᵒC in 4% PFA and cryoprotected in a 
30% sucrose solution in PBS for 48 hr, after which they were frozen and kept at -20ᵒC 
until sectioning. In order to detect labeled regenerating neurons, each spinal cord was 
sliced through their sagittal plane. Spinal cords were embedded with OCT (Tissue-Tek® 
O.C.T. Compound) and serial 50 μm thick frozen sections were performed in a Cryostat 
(CM 3050S, Leica). Slices were serially collected into a 24 well plate and processed for 
anti-CTβ free floating immunohistochemistry. Briefly, endogenous peroxidase was 
inhibited with H2O2, and sections were then blocked in blocking buffer (5% Normal 
Rabbit Serum, 0.3% Triton-X100 in 0.1M Phosphate Buffer) for 1 hr at room 
temperature and incubated overnight at 4ᵒC with anti-CTβ antibody (List Biologicals; 
1:30,000 diluted in blocking buffer) followed by incubation in biotinylated rabit anti-
goat IgG (Vector; 1:200 in blocking buffer). Antigen detection was performed with 
Extravidin Peroxidase (Sigma; 1:1000 in Triton-X100 Tris Buffered Saline) for 1 hr and 
development was done with diaminobenzidine (DAB) (Sigma). Sections were mounted 
with Chrome-Potassium Sulphate-gelatin solution, air dried overnight and stained with 
1% Toluidine Blue. 
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2.4 RESULTS  
2.4.1. Assessment of Recovery After Surgery 
After surgery, animals were carefully daily monitorized. Parameters such as body 
weight, mortality rate, recovery of motor function of the hind limbs, and recovery of 
bladder control were recorded in scoring sheets.  
From a total of 99 animals subjected to surgical procedures, 91 survived until the end 
of the study and only those were considered for data analysis. Animals included were 
grouped as described below (Table 2).  
 
Table 2 - Distribution of the animals through the different surgical procedures. 
Animals / Surgery SCI CL 
Male 28 28 
Female 25 10 
 
2.4.1.1 The cause of death is independent from the surgery type 
From the total 99 animals initially included in the study, 8 died within the first days 
after injury or even almost immediately after surgery (data not shown), resulting in a 
total mortality rate of 8%. Whereas in the spinal cord injury group 4% of the animals 
died, in the conditioning lesion group this rate was about 14%. These deaths were 
mostly due to bladder rupture at the time of manual voiding. Both in the spinal cord 
injury and in the conditioning lesion group, all the dead animals were male.  In spinal 
cord injured animals, 7% of the males died before the end of the study (Figure 14A), 
while in conditioning lesion this number was 21% (Figure 14B). Although only males 
have died, there is no significant statistical value that correlates the animal’s death 
with the type of surgery. 
 
 
 
34 
 
 
Figure 14 - Comparison between the percentage of males and females that died before the end of the study in 
spinal cord injury and conditioning lesion group. (A) Animals subjected to spinal cord injury (SCI). (B) Animals 
subjected to conditioning lesion (CL). Although only males have died, there is no statistical evidence that correlates 
their death with the injury type. 
 
2.4.1.2 Recovery of motor function and bladder control are independent 
from the injury type 
As a consequence of the spinal cord injury, all animals lost their hind limb motor 
function (data not shown). 68% of the animals from the spinal cord injury group and 
47% of the animals from the conditioning lesion group recovered hind limb motor 
function until the end of the study (Figure 15).  
 
 
Figure 15 - Comparison between the percentage of animals that recovered the motor function after spinal cord 
injury (SCI) and conditioning lesion (CL). 
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A similar percentage of animals from the spinal cord injury group (40%) and from the 
conditioning lesion group (42%) recovered bladder control, (Figure 16A). However, it 
was among males that this recovery was more evident. 57% of the males recovered 
their bladder control after spinal cord injury whereas only 20% of the females regained 
this function (Figure 16B). In the conditioning lesion group the bladder control 
recovery was achieved only by males, representing a total of 57% of the animals 
(Figure 16C). 
 
 
 
 
  
Figure 16 - Comparison between the percentage of animals that recovered bladder control. (A) Percentage of 
animals that recovered bladder control after spinal cord injury (SCI) and conditioning lesion (CL). (B) Animals 
subjected to spinal cord injury. (C) Animals subjected to conditioning lesion.  
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2.4.1.3 Animals did not present a significant weight loss both following 
spinal cord injury or conditioning lesion 
An important value to consider after surgical procedures, indicative of recovery, is 
body weight. An animal losing weight is an animal with a diminished or even absent 
food intake, and is frequently an evidence that the animal´s welfare is compromised. 
Animals with chronic body weight loss are not maintained in the study and humane 
end points are applied.  
Throughout the experiment none of the animals presented severe body weight loss. 
From a total of 91 animals included in the study, the majority didn´t lose more than 
12% of body weight. There were even some animals that gained weight.  Between 
injury type it was not observed a statistical difference in the body weight loss of the 
animals.  
A significant difference in weight loss was however observed between males and 
females in the spinal cord injury group (Figure 17). Although this tendency was also 
observed in the conditioning lesion group, it had no statistical significance. With an 
average body weight of 285g, males lost about 7% of their weight, while in females, 
with 181g of average body weight, this value was of only 1%. 
 
 
Figure 17 - Distribution of the animal’s body weight loss. Results are presented as % of body weight loss in a total of 
91 animals. Pearson´s Chi-Squared test: p < 0.005 (*). 
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2.4.2 Assessment of Axonal Regeneration 
Several strategies are able to promote the intrinsic axonal regeneration capacity of the 
central nervous system after injury, as already described. In our lab, the conditioning 
lesion model has been widely used in order to identify molecules that might contribute 
to this increase. 
2.4.2.1 Evaluation of axonal regeneration after conditioning lesion, in 
rats 
In order to assess axonal regeneration within the spinal cord, cholera toxin β was 
injected in the left sciatic nerve of animals with either spinal cord injury or conditioning 
lesion. Through immunohistochemistry, regenerating axons were assessed.  
  
2.4.2.1.1 The conditioning lesion increases the intrinsic capacity of 
axonal regeneration in the central nervous system of rats 
After transection, adult central nervous system axons are not able to regenerate and 
cross the glial scar formed following injury (Figure 18). However, if the spinal cord 
injury is preceded by one week by a lesion in the sciatic nerve, a reduced number of 
axons within the central nervous system gain regenerative capacity and are able to 
slightly cross the glial scar (Figure 19). 
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Figure 18 - Representative sagittal sections of the rat dorsal spinal cord after spinal cord injury. CTβ-immunolabeled 
axons are shown in dark brown. Lesioned axons (highlighted by*) fail to cross the lesion site. (A) Spinal cord section 
where the injury site is represented. D – dorsal, V – ventral, C – caudal, R – rostral. The arrow indicates the lesion 
site. (B) Zoom in on the lesion site. (Scale bar = 200 µm). 
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Figure 19 - Representative sagittal sections of the rat dorsal spinal cord after conditioning lesion. CTβ-
immunolabeled axons through the lesion site are shown in dark brown. Regenerating axons succeeded in crossing 
the lesion site. (A) Spinal cord section where the injury site is represented. D – dorsal, V – ventral, C – caudal, R – 
rostral. The arrow indicates the lesion site. (B) Zoom in on the lesion site. (Scale bar = 200 µm). 
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2.5 DISCUSSION 
Understanding the mechanisms responsible for the gain of regenerative capacity 
following conditioning lesion is one of the major goals of our group. Thus, the correct 
establishment, characterization and evaluation of this model is mandatory. To achieve 
this goal, Wistar rats were subjected to spinal cord injury or conditioning lesion. These 
animals were observed daily and their movement and bladder control recovery was 
assessed, as well as their body weight loss. 
The first conclusion of our study was that we were able to successfully establish this 
procedure in our animal facility as in our experimental setup we had a 96% survival 
rate. Nevertheless, more animals died when subjected to conditioning lesion and only 
males were affected. These deaths were mostly related with bladder voiding and not 
to the surgery itself. Since the male urethra is longer and contains a prominent bend, it 
is not surprising that bladder voiding is more difficult, often resulting in bladder 
rupture and consequent dead. Surprisingly, more dead animals occurred in the 
conditioning lesion group (14%) when compared to the spinal cord injury group (4%). 
Nevertheless, the fact that these animals were subjected to more surgical procedures 
may justify this result, since their health status is more fragile after surgeries. The rate 
of animals that recovered motor function after spinal cord injury (68%) was higher 
than that of animals after conditioning lesion (47%). It should however be noted that 
as animals with conditioning lesion have a sciatic nerve injury their motor function 
cannot be directly compared to the spinal cord injury group where both sciatic nerves 
are intact. Another noteworthy result was the identical rate in the recovery of bladder 
control between the two groups (40% in spinal cord injured animals vs 42% in the 
conditioned lesion group). Although the bladder is not directly innervated by the axons 
affected by the conditioning lesion, if any type of regenerative plasticity would be 
enhanced by the conditioning lesion, one would expect that it would lead to a 
functional improvement in these animals.  
A common consequence after spinal cord injury is weight loss [42]. Several reports 
indicate that a maximum acceptable body weight loss in rats subjected to spinal cord 
injury, is 25%. Above this value animals should be euthanized. With our procedures, 
however, none of the animals experienced this percentage of body weight loss. 
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Moreover, the body weight loss rate was equally distributed between animals 
subjected to either spinal cord injury or conditioning lesion. In fact, 24% of the animals 
subjected to these injuries gained weight. Thus, this is a good indication of the animal´s 
welfare after these surgical procedures. 
Finally, through retrograde labeling of regenerating axons it was possible to confirm 
the differences between both injury models. After spinal cord injury, regenerating 
axons were not able to cross the glial scar formed at the lesion site. However, if the 
spinal cord injury is preceded by a lesion in the sciatic nerve, axons within the central 
nervous system gained regenerative capacity and were able to slightly cross the glial 
scar. Thus, we confirmed in vivo, the enhanced intrinsic capacity of axonal 
regeneration after a conditioning lesion. This effect was previously observed in our 
group, in vitro, using cultures of dorsal root ganglion neurons, where an increase in 
neurite length was seen in conditioned dorsal root ganglion neurons. 
Finally, it is important to highlight that these surgeries are performed manually, thus a 
certain variation in, for example, the injury depth may occur.  
 
 PART 3 
EVALUATION OF THE  PARTICIPATION OF 
GSK-3β IN AXONAL REGENERATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The important thing in science 
 is not so much to obtain new facts as to  
discover new ways of thinking about them”. 
 
(William Bragg) 
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3.1 INTRODUCTION 
The reduced intrinsic growth capacity of adult central nervous system neurons and the 
poor environment for axon extension contribute greatly to the failure of central 
nervous system axonal regeneration [66]. However, if an injury to peripheral nervous 
system axons precedes the central nervous system injury, regeneration of central 
axons is increased [35]. To reveal the intrinsic mechanisms enabling central nervous 
system axonal regeneration after conditioning lesion, our group used two proteomic 
approaches that identified the GSK-3β pathway as being differentially regulated 
following conditioning lesion. GSK-3β has been described as a key regulatory kinase in 
the nervous system being regulated by phosphorylation. Under resting conditions, 
GSK-3β is constitutively active by phosphorylation of the Tyr216 residue, and 
phosphorylation of Ser9 leads to its inactivation. This inactivation has been correlated 
with the promotion of optimal axonal microtubule assembly [66]. In our model, Akt 
levels were increased following conditioning lesion (Akt leads to inactivation of GSK-3β 
by phosphorylation of Ser9), and the inactive form of GSK-3β, p-GSK3βSer9P, was also 
increased as expected due to the increase of Akt. Moreover, the phosphorylated form 
of CRMP-2 (a GSK-3β substrate) was decreased. This data suggests that the 
conditioning lesion leads to a reduction in GSK-3β activity that might be responsible for 
the increased regenerative capacity in this model.  
However, the role of GSK-3β in axonal growth following injury remains controversial. 
Dill et al, reported that inhibition of GSK-3β overcomes growth suppression of central 
nervous system inhibitory substrates and promotes axonal regeneration and functional 
recovery in vivo after central nervous system injuries [66]. In contrast Alabed et al 
showed  that GSK-3β is directly phosphorylated and inactivated by myelin-associated 
inhibitors contributing to the failure of regeneration in the central nervous system 
[68]. These findings raised doubt as to the possibility of GSK-3β inhibition being 
capable of promoting central nervous system regeneration following spinal cord injury. 
To elucidate the role that inactivation of GSK-3β plays, and the mechanism through 
which it is modulated during central nervous system axonal regeneration, we tested 
several injury models in homozygous GSK-3α/β Ser9Ala/Ser21Ala knockin mice [69]. In 
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these knockin mice, the phosphorylation sites Ser21 and Ser9 are changed to Ala [69], 
thus disabling the possibility of inactivating GSK-3 through phosphorylation. 
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3.2 OBJECTIVES  
 
The main objective of this work was to assess the role of GSK-3β in axonal 
regeneration. In order to achieve this aim we evaluated: 
1. The functional recovery of wild type and GSK-3β knockin mice post-surgery, 
particularly the ability of the different groups to regain bladder control; 
2. Axonal regeneration by retrograde tracing of regenerating axons through 
cholera toxin injection in the sciatic nerve of GSK-3β knockin and wild type mice 
after spinal cord injury or conditioning lesion.  
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3.3 MATERIALS AND METHODS  
3.3.1 Animals and Animal Care  
All animals were handled according to the European Communities Council Directive 
(86/609/EEC) and National rules and all procedures were approved by the Portuguese 
General Veterinarian Board. Animals were maintained at 22 ± 1ᵒC under a 12 hr 
light/dark cycle and fed with regular rodent chow and tap water ad libitum. All surgical 
procedures were preceded by anesthesia and at the end of the study all animals were 
euthanized and their skeletal remains were frozen and sent for incineration, according 
to the dispatch 242/96 August 13. Humane endpoints were determined trough the 
visualization of chronic pain or anomalous health status of the animal. Prolonged 
abnormal posture, respiratory distress, severe weight loss (more than 20%), continued 
porphyrin staining, self-induced trauma, rupture of the urinary bladder and persistent 
dehydration were also signs for humane endpoint.  
As animal models of injury, 8-9 weeks old homozygous GSK-3α/β21A/21A/9A/9A knockin 
mice (referred to as GSK-3 KI from now on) were used and wild type heterozygous 
littermate animals were used as control group. 
GSK-3 KI mice, kindly provided by Dario R. Alessi (MRC Protein Phosphorylation Unit, 
Dundee, Scotland) [69] were bred at our animal facilities with C57/Bl6 mice. 
Littermates were then crossed between them until the desired genotype was 
achieved. Animals were selected according to their genotype, which was confirmed at 
post natal day 10 (P10), from ear punch extracted DNA (performed at the CCgen 
service, IBMC) [69]. 
3.3.2 Surgical Procedures 
3.3.2.1 Sciatic Nerve Injury  
Animals were anesthetized with a Medetomidine and Ketamine mixture (1.0 mg/kg 
and 75.0 mg/kg body weight, respectively) via intra peritoneal injection, and 1.0 mL of 
a 5% glucose saline solution was injected subcutaneously. To expose the sciatic nerve, 
the left mid thigh was shaved and a 1.0 cm long incision was made. One drop of local 
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anesthesia (Articaine Hydrochloride / Epinephrine, 72 mg and 0.018 mg / 1.8 mL) was 
placed at the fascia lata over the sciatic nerve which was then sectioned immediately 
distally from the sciatic notch with a microscissor. The animals were awaked with 
Atipamesol (5 mg/kg) and analgesia was performed with subcutaneous injection of 
Butorphanol (1.0 mg/kg)   twice a day for 48 hr following injury. 
3.3.2.2 Spinal Cord Injury  
Animals were anesthetized as mentioned above and kept warm with heating pads. To 
compensate for the diuresis caused by anesthesia, and for the blood loss, a fluid 
supplement of 1.0 mL of 5% glucose saline solution was subcutaneously injected. The 
skin was then shaved along the vertebral column and, under a microscope, one 
incision was made through the thoracic vertebras 6 to 11 (T6-11). The vertebral 
column was exposed and with a microscisor, the thoracic vertebra 7 (T7) was removed. 
A spinal cord hemisection was then performed with an ophthalmic scalpel. Post 
surgical treatment consisted in fluid therapy with daily subcutaneous injection of 0.5 
mL of Duphalyte® and through subcutaneous injection of Butorphanol (1.0 mg/kg). 
Analgesia was applied every 12 hr for the next 72 hr after injury. Manual bladder 
voiding was performed twice a day until the end of the study or until animals 
recovered their bladder control. Wet food, supplemented with Anima Strath, was 
placed in the cage floor and the drinking water was supplied in long nipple bottles with 
0.016% Enrofloxacin, to prevent infections.  
3.3.2.3 Conditioning Lesion 
Animals were subjected to sciatic nerve injury followed by spinal cord injury one week 
later. 
3.3.2.4 Assessment of Axonal Regeneration in vivo  
Six weeks after spinal cord injury or conditioning lesion, animals were anesthetized 
and the left sciatic nerve was exposed as previously described. To label ascending 
regenerating axons, 2.0 μL of 1% Cholera Toxin β (CTβ, List Biologicals) was injected in 
the left sciatic nerve distally of the sciatic notch. The skin was then sutured and 
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analgesia was carried out as described for sciatic nerve injury procedures. Four days 
later, animals were anesthetized and transcardially perfused with 20.0 mL PBS, 
followed by 50.0 mL of 4% PFA. The spinal cords were collected, postfixed overnight at 
4ᵒC in 4% PFA and cryoprotected in a 30% sucrose solution in PBS for 48 hr, after which 
they were frozen and kept at -20ᵒC until sectioning. To detect labeled regenerating 
neurons, each spinal cord was sliced through their sagittal plane. Spinal cords were 
embedded with OCT (Tissue-Tek® O.C.T. Compound) and serial 50 μm thick frozen 
sections were performed in a Cryostat (CM 3050S, Leica). Slices were serially collected 
into a 24 well plate and processed for anti-CTβ free floating immunohistochemistry, as 
already described.  
3.3.2 Assessment of Recovery After Surgery 
The observation and evaluation of the animals was carried out by recording daily the 
body weight, by analyzing the presence of blood in the urine, and by assessment of 
recovery of bladder control and mobility. All data was recorded in scoring sheets.  
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3.4 RESULTS  
3.4.1 Assessment of Recovery After Surgery 
After surgery, a follow-up of all the animals was performed. Parameters such as body 
weight, mortality rate, recovery of functional movement of the posterior limbs, and 
recovery of bladder control, were taken into account and recorded daily in scoring 
sheets.  
From a total of 31 animals subjected to surgical procedures, only 25 survived until the 
end of the study and were considered for data analysis. Animals included in the study 
were grouped as described below (Table 3).  
 
Table 3 - Distribution of the animals through the different surgical procedures. 
Surgery /Animals GSK3 KI WT 
 Male Female Male Female 
SCI 0 4 2 1 
CL 3 5 1 9 
 
3.4.1.1 Only males died and the majority of deaths occurred within GSK-3 
KI animals subjected to conditioning lesion 
As a consequence of the spinal cord injury, animals lose the motor function of their 
posterior limbs and lose bladder control. The lack of bladder voiding can lead to low 
urinary tract infections, and in extreme situations can result in bladder rupture. Daily 
manual bladder voiding was performed in all the animals, however, not all survived to 
this clinical condition. From the 31 animals subjected to spinal cord hemissection, 6 
died within the first days after injury (data not shown). These deaths were related with 
bladder rupture either at the time of manual voiding or while the animals were freed 
in their cages. 25% of the GSK-3 KI animals died before the end of the study, while in 
wild type animals this percentage was 13% (Figure 20A). Among the dead GSK-3 KI 
animals, 75% of the deaths occurred after conditioning lesion (Figure 20B), while in the 
wild type animals 100% of deaths occurred after spinal cord injury (data not shown). 
All dead animals were males.  
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Figure 20 - Percentage of dead animals. (A) Comparison between the percentage of GSK-3 KI (KI) and wild type (WT) 
animals that died before the end of the study. (B) Percentage of GSK-3 KI animals that died after spinal cord injury 
(SCI) or conditioning lesion (CL). 
   
3.4.1.2 Constitutively active GSK-3β did not influence the motor function 
recovery 
Upon surgery, all the animals lost their hindlimb motor function (data not shown) 
which they recovered until the end of the study, irrespective of the fact that they were 
subjected to spinal cord injury or conditioning lesion and irrespective of their genotype 
(GSK-3 KI or wild type).  
3.4.1.3 Bladder control recovery was independent from the genotype 
Both GSK-3 KI and wild type animals had aproximately the same rate of recovery of 
bladder control (8.3% and 7.7% respectively, Figure 21A). However, within each 
genotype the only animals where bladder control was recovered were those subjected 
to conditioning lesion (data not shown). Among these, only females achieved this 
functional output (Figure 21B). 
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Figure 21 - Recovery of bladder control. (A) Bladder control recovery among GSK-3 KI (KI) and wild type (WT) 
animals. (B) Comparison between the recovery of bladder control among males and females. 
 
3.4.1.4 Animals did not have significant weight loss 
Body weight loss is an important value to determine whether animals are consuming 
food or not after the surgical procedure. This is one of the measures that can be 
indicative of the animal´s welfare. Severe body weight loss is often indicative of 
humane endpoint. If excessive body weight loss is observed, animals should be 
euthanized and removed from the study.  
From the beginning of the experiment, none of the animals presented chronic body 
weight loss. From a total of 25 animals included in the study, none lost more than 20% 
of their body weight; 12% of the animals lost between 11-20%; 32% had a body weight 
loss between 6-10%; and 12% of the animals did not lose more than 5% of body 
weight. A small group of animals (4%) did not change their body weight from the 
beginning of the study (Figure 22A), while 20% gained weight. Whether animals were 
subjected to spinal cord injury or conditioning lesion, the amount of body weight loss 
was not significantly different (Figure 22B). Also no differences were found between 
GSK-3 KI and wild type animals (Figure 22C). However, males lost more body weight 
than females. With 20g of average body weight, females lost an average of 2.4%, while 
males, with 26g average body weight, lost an average of 7% of their body weight 
(Figure 22D). 
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Figure 22 - Body weight loss. (A) Global body weight loss amongst all animals. Results are presented as % of animals in 
a total of 25 mice. (B) Average percentage of body weight loss between animals subjected to spinal cord injury (SCI) or 
conditioning lesion (CL). (C) Average percentage of body weight loss among GSK-3 KI (KI) and wild type (WT) animals. 
(D) Comparison between the percentage of body weight loss among males and females. 
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3.4.2 Assessment of Axonal Regeneration 
Several strategies are able to promote the intrinsic axonal regeneration capacity of the 
central nervous system after injury. In our group, the conditioning lesion model has 
been widely used to identify molecules that might contribute to this increase. 
3.4.2.1 Evaluation of Axonal Regeneration After Conditioning Lesion 
In order to assess axonal regeneration within the spinal cord, cholera toxin β (CTβ) was 
injected in the left sciatic nerve of animals subjected to either spinal cord injury or 
conditioning lesion. The regenerating axons were visualized by immunohistochemistry 
against this toxin. 
 
 
 
Figure 23 - Mouse spinal cord injury surgery. (A) Exposed spinal cord, before injury. (B) Spinal cord immediately 
after hemissection. R – rostral; C – caudal.  
3.4.2.1.1 The conditioning lesion increases the intrinsic capacity of 
axonal regeneration in the central nervous system 
After processing the tissues and performing anti-CTβ free floating 
immunohistochemistry, spinal cord sections were observed under a light microscope. 
In wild type animals, after spinal cord injury, axons in the spinal cord are not able to 
cross the lesion site (Figure 24). However, if the spinal cord injury is preceded in one 
week by a lesion in the sciatic nerve, a reduced number of axons within the central 
nervous system gain regenerative capacity and are able to slightly cross the glial scar 
(Figure 25). 
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Figure 24 - Representative sagittal sections of the dorsal spinal cord, after spinal cord injury in a wild type mouse. 
Regenerating axons fail to cross the lesion site. (A) Spinal cord section where the injury site is represented. D – 
dorsal, V – ventral, C – caudal, R – rostral. (B) Zoom in on the lesion site. CTβ-immunolabeled axons are shown in 
dark brown. The arrow points to the lesion site. (Scale bar = 200 µm). 
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Figure 25 - Representative sagittal sections of the dorsal spinal cord, after conditioning lesion in a wild type mouse. 
Regenerating axons are able to cross the lesion site. (A) Spinal cord section where the injury site is represented. D – 
dorsal, V – ventral, C – caudal, R – rostral. (B) Zoom in on the lesion site. CTβ-immunolabeled axons are shown in 
dark brown. The arrow points to the lesion site. (Scale bar = 200 µm). 
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3.4.3 Evaluation of the Role of GSK-3β in Axonal Regeneration 
Several proteins belonging to the GSK-3β pathway were previously identified in our 
group as being modified in extracts of dorsal root ganglion, when compared in animals 
that suffered spinal cord injury or conditioning lesion. It was though that this group of 
proteins could be implicated in the gain of axonal regeneration capacity after 
conditioning lesion. To confirm the involvement of this kinase in axonal regeneration, 
animals with GSK-3β constitutively active (GSK-3β KI) were used and compared with 
animals where the kinase was not altered (wild type). Both genotypes were subjected 
to either spinal cord injury or conditioning lesion. 
 
3.4.3.1 Constitutively active GSK-3β does not affect the increase in the 
intrinsic axonal regeneration capacity  
After injury, axonal regeneration in the central nervous system is abortive, meaning 
that the ability of axons to regrow is diminished or even absent. The GSK-3β pathway is 
described as having major implications in the regulation of axonal growth. We 
observed that in GSK-3 KI mice after spinal cord injury, axons were not able to cross 
the glial scar (Figure 26). Additionally, after conditioning lesion, GSK-3 KI axons were 
still capable of growing through the glial scar (Figure 27). 
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Figure 26 - Representative sagittal sections of dorsal spinal cord, after spinal cord injury in a GSK-3 KI mouse. 
Regenerating axons fail to cross the lesion site. (A) Spinal cord section where the injury site is represented. D – 
dorsal, V – ventral, C – caudal, R – rostral. (B) Zoom in on the lesion site. CTβ-immunolabeled axons are shown in 
dark brown. The arrow points to the lesion site. (Scale bar = 200 µm). 
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Figure 27 - Representative sagittal sections of the dorsal spinal cord after conditioning lesion in a GSK-3 KI mouse. 
Regenerating axons are able to cross the lesion site. (A) Spinal cord section where the injury site is represented. D – 
dorsal, V – ventral, C – caudal, R – rostral. (B) Zoom in on the lesion site. CTβ-immunolabeled axons are shown in 
dark brown. The arrow points to the lesion site. (Scale bar = 200 µm). 
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3.5 DISCUSSION 
To elucidate the role that inactivation of GSK-3β plays in the promotion of central 
nervous system axonal regeneration, we tested spinal cord injury and conditioning 
lesion in GSK-3β KI mice where the Ser21 and Ser9 phosphorylation sites were changed 
to Ala [69], thus disabling the inactivation of GSK-3 through the phosphorylation in 
these residues. Furthermore, to understand if constitutively active GSK-3β would affect 
the functional recovery in these animals, daily records of their movement and bladder 
control recovery were assessed, as well as their body weight loss. 
From the 31 animals initially subjected to surgical procedures, 25 survived until the 
end of the study with higher incidence among GSK-3 KI animals. Moreover, 75% of 
these deaths occurred after conditioning lesion. The fact that only males died can be 
justified by their urethra anatomical differences that introduce difficulties in the 
bladder voiding and, consequently, may result in easier bladder rupture that was in 
fact the major cause of death. The fact that the majority of these animals died after 
conditioning lesion can be a consequence of the increasing number of surgical 
procedures and not a consequence of the initial injury itself. 
After injury in the spinal cord, although all the animals lost their motor function, also 
all recovered it until the end of the study. As such, the fact that in GSK-3 KI, GSK-3β is 
constitutively active has no effect on recovery. Although Dill et al suggested that 
pharmacological inhibition of GSK-3 would promote locomotor function recovery, we 
were not able to confirm these results in our study. 
The recovery of bladder control was also very similar between GSK-3 KI and wild type 
animals (8.3 and 7.7% respectively). However only animals subjected to conditioning 
lesion have recovered this function.  
After spinal cord injury body weight loss is a frequent consequence [42]. In mice, 20% 
of body weight loss is the maximum acceptable. During our study, none of the animals 
had this body weight loss. Moreover, the body weight loss rate was equally distributed 
between GSK-3 KI and wild type animals subjected to either spinal cord injury or 
conditioning lesion. Moreover, 64% of the animals did not lose more than 10% body 
weight and 20% of the animals have even gained weight, which is a good indication of 
the animal’s welfare after these surgical procedures. 
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After spinal cord injury, regenerating axons are not able to cross the glial scar formed 
at the lesion site. However, after conditioning lesion, axons within the central nervous 
system are expected to gain regenerative capacity and to be able to cross the glial scar. 
In our study we confirmed the enhanced intrinsic capacity of axonal regeneration after 
a conditioning lesion also in mouse models. However, using the constitutively active 
GSK-3β KI mice, the same qualitative results were obtained. After spinal cord injury, 
axons remained unable to cross the glial scar, while after conditioning lesion axons 
were able to cross it. Moreover, these results were also confirmed in our group by in 
vitro cultures of GSK-3 KI dorsal root ganglion neurons, where an increase in neurite 
outgrowth was observed in conditioned dorsal root ganglion neurons from both GSK-3 
KI and wild type animals (data not published). According to Dill et al, inhibition of GSK-
3β trough Ser9 phosphorylation promotes axonal regeneration and functional recovery 
in vivo after central nervous system injuries [66]. On the other hand, Alabed et al 
reported that GSK-3β inactivation through Ser9 phosphorylation contributes to the 
failure of regeneration in the central nervous system [68]. However, our results show 
that the modulation of Ser9 phosphorylation does not affect axonal regeneration in 
the adult central nervous system, neither after spinal cord injury nor after conditioning 
lesion. Thus, our results show that the conditioning effect may occur independently of 
GSK-3β inactivation through Ser9 phosphorylation.  
To further confirm the role of GSK-3β in central nervous system regeneration, we will 
use other transgenic GSK-3β mouse models, namely GSK-3β knockout (KO) 
heterozygous mice [70] (where GSK-3β activity is partially reduced) and the floxed 
GSK-3β mice [71] crossed to Thy1-cre mice [72], where GSK-3β activity in neurons is 
ablated. With these animals we will determine if a diminished GSK-3β activity has a 
central role in the conditioning lesion effect. 
 
PART 4 
GENERAL CONCLUSIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“…the facts have not yet been sufficiently ascertained.  
And if at any future time they are ascertained,  
then credence must be given to the direct evidence rather  
than to the theories; and to the theories also, provided that 
the results which they show agree with what is observed”. 
 
(Aristotle) 
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GENERAL CONCLUSIONS 
Spinal cord injury is a devastating condition affecting the life of millions of people 
worldwide. Due to the number of societal and economical implications that central 
nervous system injuries have on society, there has been an increasing interest to find 
therapeutic approaches able to revert the abortive axonal regeneration in the adult 
vertebrate central nervous system. 
In our study, several animal models were used to evaluate and characterize a 
conditioning lesion model. Our strategy resulted in an improvement in the intrinsic 
capacity to promote axonal regeneration in the central nervous system. Moreover, we 
established this procedure very successfully as our animals had a very small mortality 
rate. As such, we can now widely apply this model to test new therapeutic approaches 
to identify additional molecules responsible for the gain of regenerative capacity. 
Nonetheless, the higher number of males dying during the recovery process can justify 
a preference to use females in these studies whenever possible. 
Moreover, we also established retrograde labeling of regenerating dorsal column 
axons as a good approach to assess, in vivo, axonal regeneration. 
Daily, there are new evidences that the regenerative ability of adult central nervous 
system axons is not totally lost. With the current advances in modern medicine and the 
increased interest in central nervous system axonal regeneration, we hope to 
contribute to transform a previously assumed “ailment not to be treated” in a 
treatable one. 
 
PART 5 
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“In science the credit goes to the man who convinces the world, 
 not to the man to whom the idea first occurs”.  
 
    (William Osler) 
 64 
 
REFERENCES 
 
1. Anders, H. and L. Richard, Spinal Cord Injury, I. Oxford University Press, Editor 
2010, Oxford University Press, Inc.: Oxford New York. p. 3-4. 
2. van Middendorp, J.J., G.M. Sanchez, and A.L. Burridge, The Edwin Smith 
papyrus: a clinical reappraisal of the oldest known document on spinal injuries. 
Eur Spine J, 2010. 19(11): p. 1815-23. 
3. Lifshutz, J. and A. Colohan, A brief history of therapy for traumatic spinal cord 
injury. Neurosurg Focus, 2004. 16(1): p. E5. 
4. Eltorat, I.M., History of Spinal Cord Medicine. Spinal Cord Medicine: principles 
and practice, 2003(I): p. 5-10. 
5. Nieuwenhuys, R., J. Voogd, and C. van Huijzen, The Human Central Nervous 
System. 4th Edition. ed2007: Springer. 177-178. 
6. Hanigan, W.C. and C. Sloffer, Nelson's wound: treatment of spinal cord injury in 
19th and early 20th century military conflicts. Neurosurg Focus, 2004. 16(1): p. 
E4. 
7. Kao, C.C., Comparison of healing process in transected spinal cords grafted with 
autogenous brain tissue, sciatic nerve, and nodose ganglion. Exp Neurol, 1974. 
44(3): p. 424-39. 
8. Ragnarsdóttir. The treatment and cure of spinal injury. Parliamentary Assembly 
2001 [cited 2011 June 20]; Available from: http://assembly.coe.int/Main.asp? 
link=/Documents/WorkingDocs/Doc01/EDOC9154.htm. 
9. Cripps, R.A., et al., A global map for traumatic spinal cord injury epidemiology: 
towards a living data repository for injury prevention. Spinal Cord, 2011. 49(4): 
p. 493-501. 
10. Spinal Cord Injury Facts and Figures at a Glance. National Spinal Cord Injury 
Statistical Center 2011 [cited 2011 June 20]; Available from: https:// 
www.nscisc.uab.edu/public_content/pdf/Facts%202011%20Feb%20Final.pdf. 
11. Spinal Cord Injury Statistics. BrainandSpinalCord.org 2011  [cited 2011 June 20]; 
Available from: http://www.brainandspinalcord.org/spinal-cordinjury/statistics 
.htm. 
12. Nolte, J., The Human Brain. An Introduction to Its Functional Anatomy. 6th 
Edition. ed2009., Philadelphia.: Mosby Elsevier. 1-2. 
13. Watson, C. and e. all., The Spinal Cord., in A Christopher and Dana Reeve 
Foundation Text and Atlas.2009., Elsevier. p. 1-2. 
14. Herbrandson, C. Nervous tissue. Learning the Nervous System 2005  [cited 2011 
July 20]; Available from: http://academic.kellogg.edu/herbrandsonc/bio201 
_mckinley/Nervous%20System.htm. 
15. Peripheral Nervous System. Students Corner  [cited 2011 July 17]; Available 
from:http://sciencecity.oupchina.com.hk/biology/student/glossary/img/periph
eral_nervous_system.jpg. 
16. Purves, D., et al., Neuroscience, 2004, Sinauer Associates, Inc.: U.S.A. 
17. Thuret, S., L.D. Moon, and F.H. Gage, Therapeutic interventions after spinal cord 
injury. Nat Rev Neurosci, 2006. 7(8): p. 628-43. 
18. McDonald, J.W. and C. Sadowsky, Spinal-cord injury. Lancet, 2002. 359(9304): 
p. 417-25. 
 65 
 
19. Tetzlaff, W., K. Fouad, and B. Kwon, Be careful what you train for. Nat Neurosci, 
2009. 12(9): p. 1077-9. 
20. He, Z. Intrinsic control of axon regeneration. Journal of Biomedical Research, 
2010. 24, 2-5. 
21. Horner, P.J. and F.H. Gage, Regenerating the damaged central nervous system. 
Nature, 2000. 407(6807): p. 963-70. 
22. Webb, A.A., S. Ngan, and J.D. Fowler, Spinal cord injury I: A synopsis of the basic 
science. Can Vet J, 2010. 51(5): p. 485-92. 
23. Giger, R.J., E.R. Hollis, and M.H. Tuszynski, Guidance molecules in axon 
regeneration. Cold Spring Harb Perspect Biol, 2010. 2(7): p. a001867. 
24. Zurn, A.D. and C.E. Bandtlow, Regeneration failure in the CNs: cellular and 
molecular mechanisms. Adv Exp Med Biol, 2006. 557: p. 54-76. 
25. Sun, F. and Z. He, Neuronal intrinsic barriers for axon regeneration in the adult 
CNS. Curr Opin Neurobiol, 2010. 20(4): p. 510-8. 
26. Vargas, M.E. and B.A. Barres, Why is Wallerian degeneration in the CNS so 
slow? Annu Rev Neurosci, 2007. 30: p. 153-79. 
27. Fenrich, K. and T. Gordon, Canadian Association of Neuroscience review: axonal 
regeneration in the peripheral and central nervous systems--current issues and 
advances. Can J Neurol Sci, 2004. 31(2): p. 142-56. 
28. Fitch, M.T. and J. Silver, CNS injury, glial scars, and inflammation: Inhibitory 
extracellular matrices and regeneration failure. Exp Neurol, 2008. 209(2): p. 
294-301. 
29. Liu, L., M. Rudin, and E.N. Kozlova, Glial cell proliferation in the spinal cord after 
dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp Brain Res, 
2000. 131(1): p. 64-73. 
30. Fawcett, J.W. and R.A. Asher, The glial scar and central nervous system repair. 
Brain Res Bull, 1999. 49(6): p. 377-91. 
31. Kimura-Kuroda, J., et al., An in vitro model of the inhibition of axon growth in 
the lesion scar formed after central nervous system injury. Mol Cell Neurosci, 
2010. 43(2): p. 177-87. 
32. Silver, J. and J.H. Miller, Regeneration beyond the glial scar. Nat Rev Neurosci, 
2004. 5(2): p. 146-56. 
33. Cao, Z., et al., The cytokine interleukin-6 is sufficient but not necessary to mimic 
the peripheral conditioning lesion effect on axonal growth. J Neurosci, 2006. 
26(20): p. 5565-73. 
34. Bareyre, F.M., et al., The injured spinal cord spontaneously forms a new 
intraspinal circuit in adult rats. Nat Neurosci, 2004. 7(3): p. 269-77. 
35. Abe, N. and V. Cavalli, Nerve injury signaling. Curr Opin Neurobiol, 2008. 18(3): 
p. 276-83. 
36. Silver, J., CNS regeneration: only on one condition. Curr Biol, 2009. 19(11): p. 
R444-6. 
37. Taoka, Y. and K. Okajima, Spinal cord injury in the rat. Prog Neurobiol, 1998. 
56(3): p. 341-58. 
38. Carlstedt, T., Perspectives on the treatment of the longitudinal spinal cord 
injury. Front Neurol, 2010. 1: p. 11. 
39. Aguilar, J., et al., Spinal cord injury immediately changes the state of the brain. J 
Neurosci, 2010. 30(22): p. 7528-37. 
 66 
 
40. Raineteau, O., et al., Reorganization of descending motor tracts in the rat spinal 
cord. Eur J Neurosci, 2002. 16(9): p. 1761-71. 
41. Wu, L.K. and X. Wang. Stem cell treatment for SCI. Wu Stem Cells Medical 
Centre 2011  [cited 2011 August 30]. 
42. Primeaux, S.D., M. Tong, and G.M. Holmes, Effects of chronic spinal cord injury 
on body weight and body composition in rats fed a standard chow diet. Am J 
Physiol Regul Integr Comp Physiol, 2007. 293(3): p. R1102-9. 
43. Leung, P.Y., C.S. Johnson, and J.R. Wrathall, Comparison of the effects of 
complete and incomplete spinal cord injury on lower urinary tract function as 
evaluated in unanesthetized rats. Exp Neurol, 2007. 208(1): p. 80-91. 
44. Yoshimura, N., Bladder afferent pathway and spinal cord injury: possible 
mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol, 
1999. 57(6): p. 583-606. 
45. de Groat, W.C., A neurologic basis for the overactive bladder. Urology, 1997. 
50(6A Suppl): p. 36-52; discussion 53-6. 
46. de Groat, W.C., et al., Developmental and injury induced plasticity in the 
micturition reflex pathway. Behav Brain Res, 1998. 92(2): p. 127-40. 
47. Yu, X., et al., Effect of spinal cord injury on urinary bladder spinal neural 
pathway: a retrograde transneuronal tracing study with pseudorabies virus. 
Urology, 2003. 62(4): p. 755-9. 
48. Apodaca, G., et al., Disruption of bladder epithelium barrier function after spinal 
cord injury. Am J Physiol Renal Physiol, 2003. 284(5): p. F966-76. 
49. Rossignol, S., Locomotion and its recovery after spinal injury. Curr Opin 
Neurobiol, 2000. 10(6): p. 708-16. 
50. Onifer, S.M., A.G. Rabchevsky, and S.W. Scheff, Rat models of traumatic spinal 
cord injury to assess motor recovery. ILAR J, 2007. 48(4): p. 385-95. 
51. Griffin, J.W., et al., Measuring nerve regeneration in the mouse. Exp Neurol, 
2010. 223(1): p. 60-71. 
52. Neumann, S. and C.J. Woolf, Regeneration of dorsal column fibers into and 
beyond the lesion site following adult spinal cord injury. Neuron, 1999. 23(1): p. 
83-91. 
53. Enes, J., et al., Electrical activity suppresses axon growth through Ca(v)1.2 
channels in adult primary sensory neurons. Curr Biol, 2010. 20(13): p. 1154-64. 
54. Ylera, B., et al., Chronically CNS-injured adult sensory neurons gain regenerative 
competence upon a lesion of their peripheral axon. Curr Biol, 2009. 19(11): p. 
930-6. 
55. Plunet, W., B.K. Kwon, and W. Tetzlaff, Promoting axonal regeneration in the 
central nervous system by enhancing the cell body response to axotomy. J 
Neurosci Res, 2002. 68(1): p. 1-6. 
56. Hoffman, P.N., A conditioning lesion induces changes in gene expression and 
axonal transport that enhance regeneration by increasing the intrinsic growth 
state of axons. Exp Neurol, 2010. 223(1): p. 11-8. 
57. Buchser, W.J., et al., Kinase/phosphatase overexpression reveals pathways 
regulating hippocampal neuron morphology. Mol Syst Biol, 2010. 6: p. 391. 
58. Kaytor, M.D. and H.T. Orr, The GSK3 beta signaling cascade and 
neurodegenerative disease. Curr Opin Neurobiol, 2002. 12(3): p. 275-8. 
 67 
 
59. Rayasam, G.V., et al., Glycogen synthase kinase 3: more than a namesake. Br J 
Pharmacol, 2009. 156(6): p. 885-98. 
60. Prickaerts, J., et al., Transgenic mice overexpressing glycogen synthase kinase 
3beta: a putative model of hyperactivity and mania. J Neurosci, 2006. 26(35): p. 
9022-9. 
61. Simón, D., et al., Pharmacological inhibition of GSK-3 is not strictly correlated 
with a decrease in tyrosine phosphorylation of residues 216/279. J Neurosci Res, 
2008. 86(3): p. 668-74. 
62. Phukan, S., et al., GSK3beta: role in therapeutic landscape and development of 
modulators. Br J Pharmacol, 2010. 160(1): p. 1-19. 
63. Salcedo-Tello, P., A. Ortiz-Matamoros, and C. Arias, GSK3 Function in the Brain 
during Development, Neuronal Plasticity, and Neurodegeneration. Int J 
Alzheimers Dis, 2011. 2011: p. 189728. 
64. Cohen, P. and M. Goedert, GSK3 inhibitors: development and therapeutic 
potential. Nat Rev Drug Discov, 2004. 3(6): p. 479-87. 
65. Zhou, F.Q. and W.D. Snider, CELL BIOLOGY: GSK-3beta and Microtubule 
Assembly in Axons. Science, 2005. 308(5719): p. 211-214. 
66. Dill, J., et al., Inactivation of glycogen synthase kinase 3 promotes axonal 
growth and recovery in the CNS. J Neurosci, 2008. 28(36): p. 8914-28. 
67. Stoll, G. and H.W. Müller, Nerve injury, axonal degeneration and neural 
regeneration: basic insights. Brain Pathol, 1999. 9(2): p. 313-25. 
68. Alabed, Y.Z., et al., GSK3 beta regulates myelin-dependent axon outgrowth 
inhibition through CRMP4. J Neurosci, 2010. 30(16): p. 5635-43. 
69. McManus, E.J., et al., Role that phosphorylation of GSK3 plays in insulin and 
Wnt signalling defined by knockin analysis. EMBO J, 2005. 24(8): p. 1571-83. 
70. Hoeflich, K.P., et al., Requirement for glycogen synthase kinase-3beta in cell 
survival and NF-kappaB activation. Nature, 2000. 406(6791): p. 86-90. 
71. Tanabe, K., et al., Genetic deficiency of glycogen synthase kinase-3beta corrects 
diabetes in mouse models of insulin resistance. PLoS Biol, 2008. 6(2): p. e37. 
72. Young, P., et al., Single-neuron labeling with inducible Cre-mediated knockout in 
transgenic mice. Nat Neurosci, 2008. 11(6): p. 721-8. 
 
 
 
 
 
 
  
  
  
 
 
